The Hypoprothrombinemia Treatment Market is anticipated to gain exponential industry growth over the given forecast period of 2022-2028. Hypoprothrombinemia is a rare bleeding disorder caused by a deficiency of prothrombin (factor II), a blood clotting substance produced by the liver. This deficiency results in dysfunction of blood clotting mechanisms, increasing the physiological risk of spontaneous […]
